1. Gadolinium-containing copolymeric chelates—a new potential MR contrast agent
- Author
-
Guanli Wu, Dekang Shen, Terry O. Matsunaga, Theodore P. Trouard, Evan C. Unger, and Leah Stewart
- Subjects
Gadolinium DTPA ,Polymers ,Gadolinium ,Biophysics ,Contrast Media ,chemistry.chemical_element ,Polyethylene glycol ,Polyethylene Glycols ,chemistry.chemical_compound ,Polypropylene glycol ,Nuclear magnetic resonance ,In vivo ,PEG ratio ,Animals ,Radiology, Nuclear Medicine and imaging ,Chelation ,cardiovascular diseases ,Chelating Agents ,chemistry.chemical_classification ,Radiological and Ultrasound Technology ,Water ,Polymer ,Pentetic Acid ,Image Enhancement ,Magnetic Resonance Imaging ,Molecular Weight ,Monomer ,chemistry ,Propylene Glycols ,cardiovascular system ,Rabbits ,Magnetic Resonance Angiography - Abstract
Rationale and objectives: To develop and partially characterize a new class of potential blood pool magnetic resonance (MR) contrast agents.Methods: Various copolymeric chelates of gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) were prepared with differing molecular weights of polyethylene glycol (PEG) or polypropylene glycol (PPG) as linkers between the monomeric chelate units. Gadolinium content of the polymeric chelates was determined by atomic absorption spectra. Relaxivity of the polymeric chelates was measured at 1.5 Tesla and compared with Gadolinium-DTPA. MR angiography (MRA) was performed in rabbits comparing Gd-DTPA with Gd-copolymers.Results: The gadolinium content of the copolymeric chelates ranged from 2.95 to 22.2% on weight basis. The molecular weight of the PEG linkers in the copolymers ranged from about 150 to about 3400. Ther1 (1/T1, mM−1 s−1) for Gd-DTPA=4.1. Ther1 values for the different Gd-containing polymers ranged from 3.8 to 5.8, with the lowestr1 for the polymer prepared with the lowest-molecular-weight complex. The higher-molecular-weight complexes resulted in moderately higher relaxivity. MRA with Gd-copolymers, in rabbits, showed markedly greater vascular enhancement relative to an equivalent dose of Gd-DTPA. Vascular enhancement was much more sustained with the copolymeric agent and confined to vascular space; i.e. no appreciable background tissue enhancement—a reflection of distribution into extravascular fluid space—was observed.Conclusions: Relative to Gd-DTPA monomers, PEG-containing Gd-DTPA polymeric complexes provided moderate increases in relaxivity but markedly greater efficacy during in vivo MRA. In vitro relaxivity studies of Gd-copolymers showed only an approximately 50% increase inr1 relaxivity compared with Gd-DTPA. The PEG-containing complex's lack of rigidity may have diminished the effect of spin diffusion on relaxation, thereby accounting for this modest increase. The greater efficacy of Gd-copolymers during in vivo MRA may reflect compartmentalization within the vascular space and possibly enhanced relaxation of the macromolecular copolymers in the blood. Gd-copolymers are promising agents that merit additional study.
- Published
- 1999